×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CSBR – champions oncology, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CSBR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/4
06:23 am
csbr
Champions Oncology (NASDAQ:CSBR) shareholders have endured a 61% loss from investing in the stock three years ago [Yahoo! Finance]
Medium
Report
Champions Oncology (NASDAQ:CSBR) shareholders have endured a 61% loss from investing in the stock three years ago [Yahoo! Finance]
10/16
12:22 pm
csbr
Champions Oncology Announces Agreement with Weill Cornell Medicine [Yahoo! Finance]
Low
Report
Champions Oncology Announces Agreement with Weill Cornell Medicine [Yahoo! Finance]
10/16
10:55 am
csbr
Champions Oncology Announces Agreement with Weill Cornell Medicine
Medium
Report
Champions Oncology Announces Agreement with Weill Cornell Medicine
9/24
04:04 pm
csbr
Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business [Yahoo! Finance]
Low
Report
Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business [Yahoo! Finance]
9/11
09:39 pm
csbr
Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript [Seeking Alpha]
9/11
04:14 pm
csbr
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million [Yahoo! Finance]
High
Report
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million [Yahoo! Finance]
9/11
04:00 pm
csbr
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
Medium
Report
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
9/9
04:00 pm
csbr
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024
Medium
Report
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/18
12:14 pm
csbr
Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 12 Filed by: Breitfeld Philip P.
Low
Report
Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 12 Filed by: Breitfeld Philip P.
11/18
11:48 am
csbr
Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 12 Filed by: SIDRANSKY DAVID
Low
Report
Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 12 Filed by: SIDRANSKY DAVID
11/18
11:19 am
csbr
Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 12 Filed by: Mendelson Daniel Newman
Low
Report
Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 12 Filed by: Mendelson Daniel Newman
11/18
11:09 am
csbr
Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 12 Filed by: TOBIN SCOTT R
Low
Report
Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 12 Filed by: TOBIN SCOTT R
11/18
11:00 am
csbr
Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 12 Filed by: ACKERMAN JOEL
Medium
Report
Form 4 CHAMPIONS ONCOLOGY, INC. For: Nov 12 Filed by: ACKERMAN JOEL
11/14
09:53 am
csbr
Form SC 13G/A CHAMPIONS ONCOLOGY, INC. Filed by: West Elk Partners, LP
Low
Report
Form SC 13G/A CHAMPIONS ONCOLOGY, INC. Filed by: West Elk Partners, LP
11/1
09:05 am
csbr
Form 4 CHAMPIONS ONCOLOGY, INC. For: Oct 31 Filed by: ACKERMAN JOEL
Medium
Report
Form 4 CHAMPIONS ONCOLOGY, INC. For: Oct 31 Filed by: ACKERMAN JOEL
10/30
04:03 pm
csbr
Form S-8 CHAMPIONS ONCOLOGY, INC.
Medium
Report
Form S-8 CHAMPIONS ONCOLOGY, INC.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/12
Form 8-K CHAMPIONS ONCOLOGY, INC. For: Jan 31
36.8%
9/5 Form 8-K CHAMPIONS ONCOLOGY, INC. For: Sep 05 9.4%
10/16 Form 8-K CHAMPIONS ONCOLOGY, INC. For: Oct 16 7.2%
3/30 Form 4 CHAMPIONS ONCOLOGY, INC. For: Mar 26 Filed by: Mendelson Daniel Newman 6.3%
3/16 Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jan 31 5.3%
3/27 Champions Oncology Inc (NASDAQ: CSBR) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.8%
12/4 Form 4 CHAMPIONS ONCOLOGY, INC. For: Dec 02 Filed by: ACKERMAN JOEL 4.4%
3/24 Form 4 CHAMPIONS ONCOLOGY, INC. For: Mar 20 Filed by: Morris Ronnie 4.3%
9/16 Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jul 31 3.7%
1/22 Champions Oncology Inc (NASDAQ: CSBR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.25 price target on the stock. 3.7%
9/5 Form 8-K CHAMPIONS ONCOLOGY, INC. For: Sep 05 9.4%
10/16 Form 8-K CHAMPIONS ONCOLOGY, INC. For: Oct 16 7.2%
3/30 Form 4 CHAMPIONS ONCOLOGY, INC. For: Mar 26 Filed by: Mendelson Daniel Newman 6.3%
3/16 Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jan 31 5.3%
3/27 Champions Oncology Inc (NASDAQ: CSBR) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.8%
12/4 Form 4 CHAMPIONS ONCOLOGY, INC. For: Dec 02 Filed by: ACKERMAN JOEL 4.4%
3/24 Form 4 CHAMPIONS ONCOLOGY, INC. For: Mar 20 Filed by: Morris Ronnie 4.3%
9/16 Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jul 31 3.7%
1/22 Champions Oncology Inc (NASDAQ: CSBR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.25 price target on the stock. 3.7%
TOP News Decliners
12/16
Form 8-K CHAMPIONS ONCOLOGY, INC. For: Dec 16
-18.8%
7/15 Champions Oncology Reports Record Quarterly Revenue of $7.7 Million For The Fourth Quarter Ended April 30, 2019 -15.2%
9/16 Q1/2020 7/31/2019 EPS -0.060 ZacksConsensus 0.040 ActVsEst (0.100) - Miss -14.2%
3/17 Champions Oncology Inc (NASDAQ: CSBR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $5.50 price target on the stock. -12.2%
3/10 Form 4 CHAMPIONS ONCOLOGY, INC. For: Mar 06 Filed by: Sonsini Peter W. -7.5%
3/10 Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2020 -6.5%
8/28 Form DEF 14A CHAMPIONS ONCOLOGY, INC. For: Apr 30 -5.1%
11/18 Champions Oncology Inc (NASDAQ: CSBR) is now covered by analysts at Benchmark Co.. They set a "buy" rating on the stock. -5.0%
3/12 Form 4 CHAMPIONS ONCOLOGY, INC. For: Mar 11 Filed by: TABORS R DAVID -3.9%
11/27 Champions Oncology Inc (NASDAQ: CSBR) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $11.00 price target on the stock. -3.3%
7/15 Champions Oncology Reports Record Quarterly Revenue of $7.7 Million For The Fourth Quarter Ended April 30, 2019 -15.2%
9/16 Q1/2020 7/31/2019 EPS -0.060 ZacksConsensus 0.040 ActVsEst (0.100) - Miss -14.2%
3/17 Champions Oncology Inc (NASDAQ: CSBR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $5.50 price target on the stock. -12.2%
3/10 Form 4 CHAMPIONS ONCOLOGY, INC. For: Mar 06 Filed by: Sonsini Peter W. -7.5%
3/10 Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2020 -6.5%
8/28 Form DEF 14A CHAMPIONS ONCOLOGY, INC. For: Apr 30 -5.1%
11/18 Champions Oncology Inc (NASDAQ: CSBR) is now covered by analysts at Benchmark Co.. They set a "buy" rating on the stock. -5.0%
3/12 Form 4 CHAMPIONS ONCOLOGY, INC. For: Mar 11 Filed by: TABORS R DAVID -3.9%
11/27 Champions Oncology Inc (NASDAQ: CSBR) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $11.00 price target on the stock. -3.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: